Nimetamine

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA

ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE

ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Assessing progress towards the global diabetes targets in WHO European region

/4

Online via zoom 25 Apr. 2024 Monday 13th May 11:00 – 12:30 CET Original: English

Provisional programme

10:45 – 11:00 Technical checks for speakers

11:00 – 11:10 Opening

 Welcome and introductions

11:10 – 11:25 Background and context

 Briefing on policy context and purpose of initiative

 This presentation will introduce the strategic context for the global diabetes targets, alongside the WHO/Europe initiative and rationale. This will include a summary of current progress against the targets in WHO Europe, and current limitations.

11:25 – 11:50 Measuring the global diabetes targets

 National perspectives Examples from countries

 This presentation will provide country examples on how the five diabetes targets could be measured in specific national contexts, alongside strengths and limitations.

Questions and answers

11:50 – 12:20 Towards a European picture of the diabetes targets

 Guided discussions

 Guided discussions will provide an opportunity to discuss reflections on how to measure the targets in different country settings, and future involvement in the WHO/Europe initiative.

12:20 – 12:25 Summary of discussions

12:25 – 12:30 Next steps and close of meeting

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA

ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE

ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Assessing progress towards the global diabetes targets in WHO European region

Online via zoom 25 Apr. 2024 Monday 13th May 11:00 – 12:30 CET Original: English

Scope and purpose

The epidemic of diabetes continues to increase in the WHO European region; according to International Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly (WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and, 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030 Agenda for Sustainable Development, and the global and European action plans for the prevention and control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO Global Diabetes Compact initiative. In November 2023, WHO Regional Office for Europe and International Diabetes Federation Europe held a high-level technical summit to accelerate commitments on diabetes across the WHO European region. During the summit, WHO/Europe presented an update of progress towards the diabetes targets, which highlighted two key issues. Firstly, there are apparently significant data gaps for the Region, for some targets more than others. Secondly, the current picture of progress suggests significant gaps in outcomes, with few Member States achieving any target. Overall, there is currently not a clear picture of progress against the diabetes targets in the WHO European region, and possibly also at national level. WHO Regional Office for Europe has embarked on an initiative in 2024 to get a more robust assessment of performance against the global diabetes targets across the WHO European region. A more robust picture will ultimately help to identify gaps and support targeted action to improve outcomes for individuals with diabetes across the region, contributing to wider noncommunicable disease targets. The WHO Regional Office for Europe initiative has firstly involved collaboration with technical experts to determine different approaches for how the targets can be measured across the region and within countries. Subsequently, WHO Regional Office for Europe will work with several Member States to assess the targets within their country. Finally, WHO Regional Office for Europe will create a summary brief to share learning across the region on how targets can be measured at the national level, and across the Region using varied case-studies from Member States. This meeting brings together representatives from Member States and aims to help build a picture of how the targets can be measured within countries. The meeting objectives include to familiarise Member States with the global targets, discuss different approaches for how the targets can be measured through examples from different national contexts, and facilitate discussion on key considerations in assessing the targets in-country.

Scope and purpose page 2 Following the meeting, interested Member States may wish to follow up within their country and/or with WHO Regional Office for Europe to gather good practice on how to measure the targets. The meetings are for invited participants only.

Saatja: EURO NCD <[email protected]>

Saadetud: 26.04.2024 14:22

Adressaat: <=?Windows-1252?Q?Helen_S=F5ber?=>

Koopia: <"Triin Uusberg">; <"SM Info">; <[email protected]>; Kaisa.Mitt-

Alvarez <[email protected]>; <[email protected]>;

<[email protected]>; KÖHLER, Kristina <[email protected]>

Teema: Nomination - Assessing progress towards the global diabetes

targets in WHO European region - online meeting - Monday 13th May 11:00 –

12:30 CET

Dear colleagues,

Attached please find an invitation letter from Dr Gauden Galea, Strategic

Adviser to the Regional Director, to submit nominations for the upcoming

online Meeting on Global Diabetes Targets in the WHO European region,

along with the Scope &amp; Purpose and the Provisional Programme. The

online meeting will take place on 13 May 2024.

Best regards,

Alex Monich

Special Initiative on NCDs and Innovation

World Health Organization

Regional Office for Europe

UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Denmark

Fax: +45 45 33 70 01 Website: https://www.who.int/europe

WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ

WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ

Date: 26 April 2024 Ms Helen Sõber Adviser European Union Affairs and International Co- operation Department Ministry of Social Affairs Suur-Ameerika 1 10122 Tallinn Estonia

REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L’EUROPE

REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО

Head office:

UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark

Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Email: [email protected]

Website: https://www.who.int/europe

Our reference: Notre référence: Unser Zeichen: См. наш номер:

Your reference: Votre référence: Ihr Zeichen: На Ваш номер:

Dear Ms Sõber,

Regional meeting on assessing progress towards the global diabetes targets in the WHO

European Region, online, 13th May 2024 (11:00 – 12:30 CET).

I have the honour to inform you that the WHO Regional Office for Europe plans to hold the above- mentioned meeting. Diabetes is one of the most common chronic conditions in Europe. At least 64 million adults and around 300 000 children and adolescents are estimated to be living with diabetes in the WHO European Region. Furthermore, according to International Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly (WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring. The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030 Agenda for Sustainable Development, and the global and European action plans for the prevention and control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO Global Diabetes Compact initiative. However, there is currently not a clear picture of progress against the diabetes targets in the WHO European Region, and possibly also at national level. To support Member States, the WHO Regional Office for Europe is launching an initiative to get a more robust assessment of progress against the global diabetes targets in the WHO European Region and in-country. Assessment of the global diabetes targets across the region can help to support targeted action, reduce disparities, and improve outcomes for those living with diabetes.

– 2 –

On Monday 13th May (11:00 – 12:30 CET), WHO Regional Office for Europe will hold a regional online technical workshop. The workshop aims to help build a picture of how the targets can be measured within countries, specifically through sharing examples from different national contexts. Further detail on the workshop is available in the attached scope and purpose. The working languages will be English and Russian, and simultaneous interpretation will be provided. In this regard, we would like to ask for your nomination of two participants to take part in the workshop. You may wish to consider the following:

 Leaders working in diabetes, such as chief endocrinologists or heads of national diabetes programmes;

 Technical experts working in non-communicable disease surveillance, eHealth or diabetes registers.

I would be grateful if you could share the contact details (name, functional title, and email address) of the nominated representatives by Monday 6 May 2024. Please send the nominations by email to Anita Strandsbjerg ([email protected]). For questions about the workshop content please contact Dr Jill Farrington, Regional Medical Officer, Cardiovascular Disease and Diabetes ([email protected]). Sincerely yours,

Encls: Provisional programme Scope and purpose Copy for information to: Ms Triin Uusberg, Head, European Union Affairs and International Co-operation Department, Ministry of Social Affairs, Suur-Ameerika 1, 10129 Tallinn, Estonia H.E. Ms Riia Salsa-Audiffren, Ambassador Representative of the Republic of Estonia, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève, Switzerland H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia